Strategic Operational Excellence in Life Sciences is a brand new forum, designed for and by strategic operations and operational excellence leaders in the Life Sciences, with a vision to create a holistic, enterprise-wide dialogue around business excellence innovation, to ultimately redefine operational excellence as a competitive advantage for the modern scientific organization. It will shine a […]

Network with over 50 other industry pioneers including Ionis Pharmaceuticals, Genentech, Vicore and AnaMar to hear first-hand how the latest scientific research is innovating and upgrading ILD therapeutics at this trailblazing new meeting. The 1st Interstitial Lung Disease Drug Development Summit is a ground-breaking new conference dedicated to helping you drive forward the development of […]

As diverse programs are advancing towards the clinic, there is a dire need to tackle the many translational challenges neuro-immunologists are facing to develop clinically effective neuroimmunology targeted therapeutics. Building on the success of last year’s meeting, the 3rd Neuroimmunology Drug Development Summit will uncover how leading companies in this emerging field are discovering immune-modulating targets […]

The Mitochondria-Targeted Drug Development Digital Summit is the only industry-led meeting focused on end-to-end mitochondria-targeting. Explore success stories from leading experts overcoming common challenges whilst exploring what’s next to help you accelerate your pipeline into the clinic. With 20+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders from Larimar Therapeutics, Minovia […]

Sponsor: Microcoat Chaired by Lynne Ensor, Vice President, RCS Head of Global Compliance, Parexel Exploring Agile Contamination Control Strategy Biologic products require diligent microbial control because of their complex and sometimes growth-promoting manufacturing processes, and high-risk patient populations. The increase in complexity of pharmaceutical products, rise in development of biologics and increasingly stringent regulations for biologics […]

Improving the Safety, Efficacy & Predictability of Monotherapy & Combinatorial Therapies to Fast-track the Discovery & Development of TNBC Treatments to Reach Patients in Need This is the primary industry platform specifically dedicated to providing you insight into the latest developments of safe and efficacious blockbuster therapies to treat triple negative breast cancer. Breast cancer […]

The Global NASH Congress programme creates a collaborative environment in which you can create enduring relationships across the full range of disciplines engaged in NASH research & drug discovery and development. Learn how to integrate NAFLD Screening into secondary and tertiary care Discover the regulatory pathways for approval of biomarkers in NAFLD patients Review the […]

Advance Cutting-Edge Research and Development with Next-Generation Cell Therapies, to Deliver Best-in-Class Products to Patients in Need Cell therapies hold life-saving potential for patients, and the race is on to develop best-in-class, living, ‘thinking’ drugs. Relapse rates and barriers to solid tumor efficacy mean the cell therapy industry must innovate, now more than ever.  The inaugural Multi-Functional Cell Therapies Summit gathers the avantgarde to […]

The first ever meeting purpose-built for discussing the advancement of curative therapies for chronic HBV infection.  Featuring an all-star speaker faculty from across industry, NGOs and academia, all dedicated to finding a curative therapy for Chronic HBV infection.  This is a unique opportunity to review the latest clinical investigations with novel and classic therapeutics including […]

Innovations in HPAPI Containment & Facility Design for Successful Manufacturing Sponsored by: Catalent Pharma Solutions and FPS Food and Pharma Systems Chaired by: Justin Mason-Home, Director, HPAPI Project Services Limited SMi is delighted to announce its 5th Annual Highly Potent Active Pharmaceutical Ingredients Virtual Conference on 10th and 11th May 2021. Highly Potent Active Pharmaceutical Ingredients (HPAPIs) […]

Sponsored by: MD Biosciences and Transpharmation Chaired by Michael Scherz, Founder & CEO, Metys Pharma and Naheed Mirza, Early Development Pain & CNS Specialist Explore Cutting Edge Drug Discovery Science and Key Clinical-Stage Pain Therapies in the Pipeline SMi’s 21st Pain Therapeutics Conference will focus on looking into research within pain therapeutics. In particular, the long-term […]

Manufacturing Assets and Facility Management in Pharma Summit returns in 2021. Taking place virtually this May 11-13, a must attend event to help modernize your facility and revitalize your asset management strategies. Join this cutting-edge discussion and network with engineering, maintenance and manufacturing facilities leaders. To know more about Manufacturing Assets and Facility Management in […]

Assessing the innovations in formulations and devices for enhanced injectable delivery  SMi Group is pleased to announce the third annual Injectable Drug Delivery conference, which will be held in London on the 12th and 13th May 2021. Part of Europe’s leading Injectable conference series, Injectable Drug Delivery will assess innovations in drug product formulation and […]

The COVID-19 pandemic brought life-changing disruptions to people around the world and has turned the typical vaccine R&D process on its head. A combination of urgent need, unprecedented investments, and advances in genetic engineering has allowed what was once mere speculation to become not only our reality, but our future. With pandemic vaccines now launching […]

After the successful four editions of Bioprocessing of Cell therapies, coming up with 5th Annual of Bioprocessing of Biotherapeutics brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for the development, manufacture and quality of protein expressions, cell, and gene therapies. The virtual event will present detailed case studies and interactive discussions […]

As the therapeutic value of manipulating previously hard-to-drug ubiquitin ligases becomes more and more evident in addressing numerous diseases with unmet clinical needs, the inaugural Ligase Targeting Drug Development Summit arrives as the dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to seize the day. Built with large pharma and […]

With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers targeting the muscle when it comes to optimizing delivery and […]

Harness the Maternal-Infant Microbiome, Establish New Mechanisms of Action, and Develop Breakthrough Health Products that Proactively Prevent Disease Risk Returning for another year, this platform will unite industry and academics in the exploration of preventative and therapeutic treatment of the microbiome during pregnancy and early life. The discussion during this 3-day conference will cover key […]

This is the definitive drug development forum for research teams to investigate how to modulate the cGAS-STING and Toll-like receptor (7/8/9) pathways both as monotherapies and as adjuvants in combinatorial approaches. This meeting comes at a critical point for the cancer immunotherapy field, as researchers look to increase patient response rates and the efficacy on checkpoint inhibitors in several […]

In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety of gene therapy products. Whether you’re looking for specific characterisation, potency or infectivity approaches to improve your current analytical toolbox or if […]

Hearing loss has a huge impact on the quality of life for millions of people, and as the average age of the population increases, the need for curative life-changing therapies targeting hearing loss and inner ear disorders has never been more important. The Inner Ear Disorders Therapeutics Summit is gathering the world’s leading biopharmaceutical companies […]

The TCR-based Therapies Summit is Dedicated to Supercharging TCR Design, Translation & Manufacturing Strategy for Solid Tumor Success Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density & binding affinity for solid tumor indications. This June (8-10), join this exclusive community […]

The inaugural Next Generation Gene Therapy Vectors meeting is dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors. Industry pioneers from cutting edge biotechs and world-leading academic vectorology groups including Dyno Therapeutics, 4D Molecular Therapeutics and Generation Bio will share how ever-increasing clinical experience is guiding strategies to decrease […]

With commitments to advancing your preclinical and translational oncology research, we are delighted to bring the 9th annual PREDiCT: Tumor Models Cell Therapy Summit to your screens in July. See best-in-class tumor models and how they can be effectively utilized to model the tumor microenvironment and further your MoA understanding for new cell therapies. Learn to improve […]

SMi are proud to announce the 5th annual conference: Pre-Filled Syringes West Coast 2020 14-15 June 2021 San Diego, CA, USA Hyatt Regency Mission Bay www.prefilled-syringes-westcoast.com/pjwl Assessing Device Development and Regulation for Advanced Innovation SMi is proud to present the 5th Annual Pre-Filled Syringes West Coast Conference in San Diego on 14th and 15th June […]

As investments and collaborations hit a record high, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases, exciting efforts have now turned to a wide range of other diseases, from CNS, oncology, metabolism and more. Despite the growing momentum, much needs to be […]

Skin microbiome products have been gaining more momentum in the last few years with more brands starting to develop products, and personal care giants either starting to develop their own product or investing in start-ups focusing on these. It is a very exciting time for companies looking into this at the moment, figuring out not only product […]

SMi’s 4th Pharmaceutical Microbiology West Coast Conference Novel approaches and best practices for tackling current industry contamination control challenges SMi’s 4th Annual Conference Pharmaceutical Microbiology West Coast NEW DATE: June 17 – 18, 2021 Location: Hyatt Regency Mission Bay Hotel, San Diego, CA, USA Website: http://www.pharma-microbiology-usa.com SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, Microcoat, Millipore […]

In its most exciting year yet the field of oncolytic virotherapy has seen the highest number of clinical read-outs, the emergence of next generation viruses, and never-before-seen combination therapies. Now in its 6th year, the Oncolytic Virotherapy Summit is the industry’s definitive guide to turning viral vehicles into clinically effective therapeutics across oncology indications. With 3 […]

Welcome to the Digital HER2-Targeted Therapies Summit 2021 - The First Conference Focused on Exploring New Frontiers of HER2 as a Pan-Tumor Target HER2 expressing patients are experiencing drug resistance, suboptimal duration of response and refractory/relapsed disease, stimulating new frontiers for HER2-targeted drug development. Impressive clinical data are being reported for next-generation anti-HER2 approaches in […]